655 related articles for article (PubMed ID: 27184175)
1. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
van der Molen T; Postma DS; Martin RJ; Herings RM; Overbeek JA; Thomas V; Miglio C; Dekhuijzen R; Roche N; Guilbert T; Israel E; van Aalderen W; Hillyer EV; van Rysewyk S; Price DB
BMC Pulm Med; 2016 May; 16(1):80. PubMed ID: 27184175
[TBL] [Abstract][Full Text] [Related]
2. Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids.
Guilbert TW; Colice G; Grigg J; van Aalderen W; Martin RJ; Israel E; Postma DS; Roche N; Phipatanakul W; Hillyer EV; Evans JM; Dolovich MB; Price DB;
J Allergy Clin Immunol Pract; 2017; 5(4):1040-1049.e4. PubMed ID: 28110057
[TBL] [Abstract][Full Text] [Related]
3. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.
Price D; Thomas M; Haughney J; Lewis RA; Burden A; von Ziegenweidt J; Chisholm A; Hillyer EV; Corrigan CJ
Respir Med; 2013 Jul; 107(7):987-1000. PubMed ID: 23643486
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
5. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
6. Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.
Postma DS; Dekhuijzen R; van der Molen T; Martin RJ; van Aalderen W; Roche N; Guilbert TW; Israel E; van Eickels D; Khalid JM; Herings RM; Overbeek JA; Miglio C; Thomas V; Hutton C; Hillyer EV; Price DB
Allergy Asthma Immunol Res; 2017 Mar; 9(2):116-125. PubMed ID: 28102056
[TBL] [Abstract][Full Text] [Related]
7. Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies.
Sonnappa S; McQueen B; Postma DS; Martin RJ; Roche N; Grigg J; Guilbert T; Gouder C; Pizzichini E; Niimi A; Phipatanakul W; Chisholm A; Dandurand RJ; Kaplan A; Israel E; Papi A; van Aalderen WMC; Usmani OS; Price DB
J Allergy Clin Immunol Pract; 2018; 6(3):907-915.e7. PubMed ID: 28941668
[TBL] [Abstract][Full Text] [Related]
8. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
Colice G; Martin RJ; Israel E; Roche N; Barnes N; Burden A; Polos P; Dorinsky P; Hillyer EV; Lee AJ; Chisholm A; von Ziegenweidt J; Barion F; Price D
J Allergy Clin Immunol; 2013 Jul; 132(1):45-54. PubMed ID: 23591272
[TBL] [Abstract][Full Text] [Related]
9. Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
van Aalderen WM; Grigg J; Guilbert TW; Roche N; Israel E; Martin RJ; Colice G; Postma DS; Hillyer EV; Burden A; Thomas V; von Ziegenweidt J; Price D
J Allergy Clin Immunol Pract; 2015; 3(5):721-31.e16. PubMed ID: 26032474
[TBL] [Abstract][Full Text] [Related]
10. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S; Rottier BL; Scholten RJ; Boluyt N
Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.
Martin RJ; Price D; Roche N; Israel E; van Aalderen WM; Grigg J; Postma DS; Guilbert TW; Hillyer EV; Burden A; von Ziegenweidt J; Colice G
NPJ Prim Care Respir Med; 2014 Oct; 24():14081. PubMed ID: 25297072
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009471. PubMed ID: 25030198
[TBL] [Abstract][Full Text] [Related]
13. Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
Cox CA; Boudewijn IM; Vroegop SJ; Schokker S; Lexmond AJ; Frijlink HW; Hagedoorn P; Vonk JM; Farenhorst MP; Ten Hacken NHT; Kerstjens HAM; Postma DS; van den Berge M
Respir Med; 2017 Sep; 130():35-42. PubMed ID: 29206631
[TBL] [Abstract][Full Text] [Related]
14. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.
Pruteanu AI; Chauhan BF; Zhang L; Prietsch SO; Ducharme FM
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009878. PubMed ID: 25030199
[TBL] [Abstract][Full Text] [Related]
15. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
Murray CS; Thomas M; Richardson K; Price DB; Turner SW
J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
[TBL] [Abstract][Full Text] [Related]
17. Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analyses.
Papi A; Virchow JC; Singh D; Kots M; Vele A; Georges G; Canonica GW
J Allergy Clin Immunol; 2021 Jul; 148(1):262-265.e2. PubMed ID: 33485959
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A; Hall I; Spelman R
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[TBL] [Abstract][Full Text] [Related]
19. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
20. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
Kanniess F; Scuri M; Vezzoli S; Francisco C; Petruzzelli S
Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
